[{"Assets_0_Q3_USD":88710000.0,"CommonStockSharesOutstanding_0_Q3_shares":48079615.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-58111000.0,"NetIncomeLoss_1_Q3_USD":-18778000.0,"NetIncomeLoss_3_Q3_USD":-60355000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46944536.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":44052470.0,"StockholdersEquity_0_Q3_USD":11301000.0,"EarningsPerShareBasic_1_Q3_USD":-0.4,"EarningsPerShareBasic_3_Q3_USD":-1.37,"Ticker":"OCUL","CIK":"1393434","name":"OCULAR THERAPEUTIX, INC","OfficialName":"Ocular Therapeutix Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"305481557.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]